Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP628100.RAZm9oB9gYLdq_n0G6nJjz_aTeNVXrzkapXtMrd2twDt0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP628100.RAZm9oB9gYLdq_n0G6nJjz_aTeNVXrzkapXtMrd2twDt0130_assertion type Assertion NP628100.RAZm9oB9gYLdq_n0G6nJjz_aTeNVXrzkapXtMrd2twDt0130_head.
- NP628100.RAZm9oB9gYLdq_n0G6nJjz_aTeNVXrzkapXtMrd2twDt0130_assertion description "[The PLA(2) enzymes, and sPLA(2)-IIA in particular, thus represent important targets for the treatment of sPLA(2)-IIA-positive androgen-independent prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628100.RAZm9oB9gYLdq_n0G6nJjz_aTeNVXrzkapXtMrd2twDt0130_provenance.
- NP628100.RAZm9oB9gYLdq_n0G6nJjz_aTeNVXrzkapXtMrd2twDt0130_assertion evidence source_evidence_literature NP628100.RAZm9oB9gYLdq_n0G6nJjz_aTeNVXrzkapXtMrd2twDt0130_provenance.
- NP628100.RAZm9oB9gYLdq_n0G6nJjz_aTeNVXrzkapXtMrd2twDt0130_assertion SIO_000772 15466184 NP628100.RAZm9oB9gYLdq_n0G6nJjz_aTeNVXrzkapXtMrd2twDt0130_provenance.
- NP628100.RAZm9oB9gYLdq_n0G6nJjz_aTeNVXrzkapXtMrd2twDt0130_assertion wasDerivedFrom befree-20150227 NP628100.RAZm9oB9gYLdq_n0G6nJjz_aTeNVXrzkapXtMrd2twDt0130_provenance.
- NP628100.RAZm9oB9gYLdq_n0G6nJjz_aTeNVXrzkapXtMrd2twDt0130_assertion wasGeneratedBy ECO_0000203 NP628100.RAZm9oB9gYLdq_n0G6nJjz_aTeNVXrzkapXtMrd2twDt0130_provenance.